Prevalencia de enfermedad celiaca en Latinoamérica: revisión sistemática de la literatura y meta-análisis

dc.contributorAnaya, Juan-Manuel
dc.creatorParra-Medina, Rafael
dc.creatorMolano-González, Nicolas
dc.creatorRojas-Villarraga, Adriana
dc.creatorAnaya, Juan-Manuel
dc.date.accessioned2014-11-12T20:00:25Z
dc.date.available2014-11-12T20:00:25Z
dc.date.created2014-11-12T20:00:25Z
dc.date.issued2014
dc.identifierhttp://repository.urosario.edu.co/handle/10336/9004
dc.identifierhttps://doi.org/10.48713/10336_9004
dc.description.abstractBackground: Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of gluten in susceptible individuals, and its prevalence varies depending on the studied population. Because information on CD in Latin America is scarce, we aimed to investigate the prevalence of CD in this region of the word through a systematic review and meta-analysis Methods and Findings: This report describes a two-phase study. First, a cross-sectional analysis from 300 individuals of the Colombian population was made. Second, a systematic review and meta-regression analysis were made following the PRISMA guidelines. Our results disclose a lack of anti-tissue transglutaminase (tTG) and IgA anti-endomysium (EMA) autoantibody in Colombians. In the systematic review, after 72 studies that met the selection criteria were considered, the estimated prevalence of CD in LA was 0,46% to 0,64%, whereas the prevalence of CD was 5,5 to 5,6% in first degree relatives of CD patients and 4,6% to 8,7% in type 1 diabetes mellitus patients. Conclusions: Our study shows that prevalence of CD in healthy patients from LA is similar to the prevalence reported in the European population.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherFacultad de medicina
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceSapone A, Bai JC, Ciacci C, Dolinsek J, Green PHR, Hadjivassiliou M, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. BioMed Central Ltd; 2012 Jan;10(1):13.
dc.sourceGujral N, Freeman HJ, Thomson ABR. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol. 2012 Nov 14;18(42):6036–59.
dc.sourceKratzer W, Kibele M, Akinli A, Porzner M, Boehm BO, Koenig W, et al. Prevalence of celiac disease in Germany: A prospective follow-up study. World J Gastroenterol. 2013 May 7;19(17):2612–20.
dc.sourceParada A, Araya M, Pérez-Bravo F, Méndez M, Mimbacas A, Motta P, et al. Amerindian mtDNA haplogroups and celiac disease risk HLA haplotypes in mixed-blood Latin American patients. J Pediatr Gastroenterol Nutr. 2011 Oct;53(4):429–34.
dc.sourceBrar P, Lee AR, Lewis SK, Bhagat G, Green PHR. Celiac disease in African-Americans. Dig Dis Sci. 2006 May;51(5):1012–5.
dc.sourceGomez JC, Selvaggio GS, Viola M, Pizarro B, la Motta G, de Barrio S, et al. Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area. Am J Gastroenterol. 2001/09/25 ed. 2001;96(9):2700–4.
dc.sourceAlmeida PL, Gandolfi L, Modelli IC, Martins Rde C, Almeida RC, Pratesi R. Prevalence of celiac disease among first degree relatives of Brazilian celiac patients. Arq Gastroenterol. 2008/04/22 ed. 2008;45(1):69–72.
dc.sourceGonzález Burchard E, Borrell LN, Choudhry S, Naqvi M, Tsai H-J, Rodriguez-Santana JR, et al. Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. Am J Public Health. 2005 Dec;95(12):2161–8.
dc.sourceRisch N, Choudhry S, Via M, Basu A, Sebro R, Eng C, et al. Ancestry-related assortative mating in Latino populations. Genome Biol. 2009 Jan;10(11):R132.
dc.sourceCatassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014 Jul;59 Suppl 1:S7–9.
dc.sourceFasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001 Feb;120(3):636–51.
dc.sourceLionetti E, Catassi C. New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment. Int Rev Immunol. 2011 Aug;30(4):219–31
dc.sourceFasano A, Catassi C. Clinical practice. Celiac disease. N Engl J Med. 2012 Dec 20;367(25):2419–26.
dc.sourceGreen PHR, Cellier C. Celiac disease. N Engl J Med. 2007 Oct 25;357(17):1731–43.
dc.sourceBai JC, Fried M, Corazza GR, Schuppan D, Farthing M, Catassi C, et al. World gastroenterology organisation global guidelines on celiac disease. J Clin Gastroenterol. 2013 Feb;47(2):121–6.
dc.sourceCatassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med. Elsevier Inc.; 2010 Aug;123(8):691–3.
dc.sourceAdmou B, Essaadouni L, Krati K, Zaher K, Sbihi M, Chabaa L, et al. Atypical Celiac Disease: From Recognizing to Managing. Gastroenterol Res Pract. 2012 Jan;2012:637187.
dc.sourceRostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C, et al. The diagnostic accuracy of serologic tests for celiac disease: A systematic review. Gastroenterology. 2005 Apr;128(4):S38–S46.
dc.sourceZintzaras E, Germenis AE. Performance of Antibodies against Tissue Transglutaminase for the Diagnosis of Celiac Disease : Meta-Analysis. 2005;187–92.
dc.sourceHusby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips a, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012 Jan;54(1):136–60.
dc.sourceBizzaro N, Tampoia M, Villalta D, Platzgummer S, Liguori M, Tozzoli R, et al. Low specificity of anti-tissue transglutaminase antibodies in patients with primary biliary cirrhosis. J Clin Lab Anal. 2006 Jan;20(5):184–9.
dc.sourceFerrara F, Quaglia S, Caputo I, Esposito C, Lepretti M, Pastore S, et al. Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. Clin Exp Immunol. 2010 Feb;159(2):217–23.
dc.source. Villalta D, Bizzaro N, Tonutti E, Tozzoli R. IgG anti-transglutaminase autoantibodies in systemic lupus erythematosus and Sjögren syndrome. Clin Chem. 2002 Jul;48(7):1133.
dc.sourceTonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, et al. Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease. J Clin Lab Anal. 2009 Jan;23(3):165–71.
dc.sourceVillanacci V, Ceppa P, Tavani E, Vindigni C, Volta U. Coeliac disease: the histology report. Dig Liver Dis. 2011 Mar;43 Suppl 4:S385–95.
dc.sourceSalmi TT, Collin P, Korponay-Szabó IR, Laurila K, Partanen J, Huhtala H, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut. 2006 Dec;55(12):1746–53.
dc.sourceKoskinen O, Villanen M, Korponay-Szabo I, Lindfors K, Mäki M, Kaukinen K. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. J Pediatr Gastroenterol Nutr. 2009 May;48(5):559–65.
dc.sourcePulido OM, Gillespie Z, Zarkadas M, Dubois S, Vavasour E, Rashid M, et al. Introduction of oats in the diet of individuals with celiac disease: a systematic review. Adv Food Nutr Res. 2009 Jan;57:235–85.
dc.sourceStan C. CODEX STANDARD FOR FOODS FOR SPECIAL DIETARY USE FOR PERSONS. 2008;3–5.
dc.sourceCatassi C, Fabiani E, Iacono G, D’Agate C, Francavilla R, Biagi F, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr. 2007 Jan;85(1):160–6.
dc.sourceNachman F, Sugai E, Vázquez H, González A, Andrenacci P, Niveloni S, et al. Serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol. 2011 Jun;23(6):473–80.
dc.sourceLanzini A, Lanzarotto F, Villanacci V, Mora A, Bertolazzi S, Turini D, et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther. 2009 Jul 15;29(12):1299–308.
dc.sourceArnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–24.
dc.sourceTan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–7.
dc.sourceVitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002 Jun;61(6):554–8.
dc.sourceLiberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009 Oct;62(10):e1–34.
dc.sourceGroup OL of EW. “The Oxford 2011 levels of evidence.”Oxford Cent Evidence-Based Med. 2011;
dc.sourceViechtbauer W. Conducting Meta-Analyses in R with the metafor Package. J Stat Softw. 2010;36(3):1–48.
dc.sourceMachado AP de SL, Silva LR, Zausner B, Oliveira J de A, Diniz DR, de Oliveira J. Undiagnosed celiac disease in women with infertility. J Reprod Med. 2013;58(1-2):61–6.
dc.sourceGomez JC, Selvaggio GS, Viola M, Pizarro B, la Motta G, de Barrio S, et al. Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area. Am J Gastroenterol. 2001 Sep;96(9):2700–4.
dc.sourceGomez JC, Selvaggio G, Pizarro B, Viola MJ, La Motta G, Smecuol E, et al. Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study. Am J Gastroenterol. 2002/11/12 ed. 2002;97(11):2785–90.
dc.sourceGonzález D, Sugai E, Gomez JC, Oliveri MB, Gomez Acotto C, Vega E, et al. Is it necessary to screen for celiac disease in postmenopausal osteoporotic women? Calcif Tissue Int. 2002;71(2):141–4.
dc.sourceRumbo M, Chirdo FG, Ben R, Saldungaray I, Villalobos R. Evaluation of coeliac disease serological markers in Down syndrome patients. Dig Liver Dis. 2002/04/03 ed. 2002;34(2):116–21.
dc.sourceMora M, Litwin N, Toca M del C, Azcona MI, Solís Neffa R, Ortiz G, et al. Prevalencia de enfermedad celíaca: estudio multicéntrico en población pediátrica en cinco distritos urbanos de Argentina. Rev argent salud publica. 2010;1(4):26–31.
dc.sourceBustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, et al. Autoantibodies in Argentine women with recurrent pregnancy loss. Am J Reprod Immunol. 2006;55(3):201–7.
dc.sourceBegué C, Beratarrechea AG, Varela E, Piccioni HL, Rodota L, Castro ME, et al. Enfermedad celíaca : prevalencia del diagnóstico en un hospital de comunidad. Acta Gastroenterol Latinoam. 2010;40(4):317–22.
dc.sourceSugai E, Moreno ML, Hwang HJ, Cabanne A, Crivelli A, Nachman F, et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable? World J Gastroenterol. 2010 Jul 7;16(25):3144–52.
dc.sourceGandolfi L, Pratesi R, Cordoba JC, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brazil. Am J Gastroenterol. 2000 Mar;95(3):689–92.
dc.sourceGandolfi L, Catassi C, Garcia S, Modelli IC, Campos Jr. D, Pratesi R. Antiendomysial antibody test reliability in children with frequent diarrhea and malnutrition: is it celiac disease? J Pediatr Gastroenterol Nutr. 2001;33(4):483–7.
dc.sourceKotze LM, Utiyama SR, Nisihara RM, Zeni MP, de Sena MG, Amarante HM. Antiendomysium antibodies in Brazilian patients with celiac disease and their first-degree relatives. Arq Gastroenterol. 2001;38(2):94–103.
dc.sourcePratesi R, Gandolfi L, Garcia SG, Modelli IC, Lopes de Almeida P, Bocca AL, et al. Prevalence of coeliac disease: unexplained age-related variation in the same population. Scand J Gastroenterol. 2003;38(7):747–50.
dc.sourcePratesi R, Gandolfi L, Martins RC, Tauil PL, Nobrega YK, Teixeira WA. Is the prevalence of celiac disease increased among epileptic patients? Arq Neuropsiquiatr. 2003;61(2B):330–4.
dc.sourceBrandt KG, Silva GAP, Antunes MMC. Celiac disease in a group of children and adolescents with type 1 diabetes mellitus. Arq Bras Endocrinol Metab 48: 823–827.
dc.sourceQueiroz MS, Nery M, Cancado EL, Gianella-Neto D, Liberman B. Prevalence of celiac disease in Brazilian children of short stature. Braz J Med Biol Res. 2004;37(1):55–60.
dc.sourceTrevisiol C, Brandt KG, Silva GA, Crovella S, Ventura A. High prevalence of unrecognized celiac disease in an unselected hospital population in north-eastern Brasil (Recife, Pernambuco). J Pediatr Gastroenterol Nutr. 2004;39(2):214–5.
dc.sourceBaptista ML, Koda YK, Mitsunori R, Nisihara, Ioshii SO. Prevalence of celiac disease in Brazilian children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr. 2005;41(5):621–4.
dc.sourceLima VM, Gandolfi L, Pires JA, Pratesi R. Prevalence of celiac disease in dyspeptic patients. Arq Gastroenterol. 2005;42(3):153–6.
dc.sourceNisihara RM, Kotze LM, Utiyama SR, Oliveira NP, Fiedler PT, Messias-Reason IT. Celiac disease in children and adolescents with Down syndrome. J Pediatr (Rio J). 2005;81(5):373–6.
dc.sourceTanure MG, Silva IN, Bahia M, Penna FJ. Prevalence of celiac disease in Brazilian children with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr. 2006 Feb;42(2):155–9.
dc.sourcePereira MA, Ortiz-Agostinho CL, Nishitokukado I, Sato MN, Damiao AO, Alencar ML, et al. Prevalence of celiac disease in an urban area of Brazil with predominantly European ancestry. World J Gastroenterol. 2006;12(40):6546–50.
dc.sourceMelo SB, Fernandes MI, Peres LC, Troncon LE, Galvao LC. Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirao Preto, State of Sao Paulo, Brazil. Dig Dis Sci. 2006;51(5):1020–5.
dc.sourceDe Bem RS, Da Ro Sa Utiyama SR, Nisihara RM, Fortunato JA, Tondo JA, Carmes ER, et al. Celiac disease prevalence in Brazilian dilated cardiomyopathy patients. Dig Dis Sci. 2006;51(5):1016–9.
dc.sourceAraújo J, Pontes Da Silva GA, De Melo FM. Serum prevalence of celiac disease in children and adolescents with type 1 diabetes mellitus. J Pediatr (Rio J). 2006;82(3):210–4.
dc.sourceCrovella S, Brandao L, Guimaraes R, Filho JL, Arraes LC, Ventura A, et al. Speeding up coeliac disease diagnosis in the developing countries. Dig Liver Dis. 2007;39(10):900–2.
dc.sourceNisihara RM, Skare TL, Silva MB. Rheumatoid Arthritis and anti-endomysial antibodies. Acta Reum Port. 2007;32(2):163–7.
dc.sourceOliveira RP, Sdepanian VL, Barreto J a, Cortez AJP, Carvalho FO, Bordin JO, et al. High prevalence of celiac disease in Brazilian blood donor volunteers based on screening by IgA antitissue transglutaminase antibody. Eur J Gastroenterol Hepatol. 2007 Jan;19(1):43–9.
dc.sourceWhitacker FCF, Hessel G, Lemos-Marini SH V, Paulino MFVM, Minicucci WJ, Guerra-Júnior G. Prevalence and clinical aspects when it comes to the association between type 1 diabetes mellitus (DM1) and celiac disease. Arq Bras Endocrinol Metab. 2008;635–41.
dc.sourceMont-Serrat C, Hoineff C, Meirelles RMR, Kupfer R. Diabetes and autoimmune diseases: prevalence of celiac disease in children and adolescents with type 1 diabetes. Arq Bras Endocrinol Metabol 2008;1461–5.
dc.sourceBrandt KG, Silva GAP da. Seroprevalence of celiac disease at a general pediatric outpatient clinic. Arq Gastroenterol 2008;239–42.
dc.sourceKoehne Vde B, Bahia M, Lanna CC, Pinto MR, Bambirra EA, Cunha AS. Prevalence of serological markers for celiac disease (IgA and IgG class antigliadin antibodies and IgA class antiendomysium antibodies) in patients with autoimmune rheumatologic diseases in Belo Horizonte, MG, Brazil. Arq Gastroenterol. 2010;47(3):250–6.
dc.sourceUtiyama SR, Ribas JL, Nisihara RM, Kotze LM, de Messias-Reason IJ. Celiac disease in native Indians from Brazil: A clinical and epidemiological survey. N Am J Med Sci. 2010;2(3):138–42.
dc.sourceMartins Rde C, Gandolfi L, Modelli IC, Almeida RC, Castro LC, Pratesi R. Serologic screening and genetic testing among brazilian patients with celiac disease and their first degree relatives. Arq Gastroenterol. 2010;47(3):257–62.
dc.sourceDias MDCS, De Castro LCG, Gandolfi L, De Almeida RC, Córdoba MS, Pratesi R. Screening for celiac disease among patients with Turner syndrome in Brasília, DF, Midwest region of Brazil. Arq Gastroenterol. 2010;47(3):246–9.
dc.sourceModelli IC, Gandolfi L, Almeida RC de, Araújo GMAC, Picanço M de A, Pratesi R. Serological screening for celiac disease in symptomatic 12 to 36 month-old children. Arq Gastroenterol. 2010;47(1):61–5.
dc.sourceCastro-Antunes MM, Magalhaes R, Nobre JM, Duarte BP, Silva GA. Celiac disease in first-degree relatives of patients. J Pediatr (Rio J). 2010;86(4):331–6.
dc.sourceNass FR, Kotze LMDS, Nisihara RM, De Messias-Reason IJ, Ramos Da Rosa Utiyama S. Serological and clinical follow-up of relatives of celiac disease patients from Southern Brazil. Digestion. 2010;83(1-2):89–95.
dc.sourceRibeiro-Cabral VL, da-Silva-Patrício FR, Ambrogini-Junior O, Jankiel-Miszputen S. Anti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn’s disease and autoimmune diabetes. Rev Esp Enferm Dig 2011;453–7.
dc.sourceGoeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, da Rosa Utiyama SR. Autoantibodies for gastrointestinal organ-specific autoimmune diseases in rheumatoid arthritis patients and their relatives. Clin Rheumatol. 2011;30(1):99–102.
dc.sourceNisihara R, Utiyama SR, Azevedo PM, Skare TL. Celiac disease screening in patients with scleroderma. Arq Gastroenterol. 2011;48(2):163–4.
dc.sourceAndretta MA, Vieira TD, Nishiara R, Skare TL. Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis. Rheumatol Int. 2012;32(2):551–4.
dc.sourceAlencar ML, Ortiz-Agostinho CL, Nishitokukado L, Damião AOMC, Abrantes-Lemos CP, Leite AZ de A, et al. Prevalence of celiac disease among blood donors in São Paulo: the most populated city in Brazil. Clinics (Sao Paulo). 2012 Sep;67(9):1013–8.
dc.sourceAlmeida RC, Gandolfi L, De Nazare Klautau-Guimaraes M, Ferrari I, Sousa SM, Abe-Sandes K, et al. Does celiac disease occur in Afro-derived Brazilian populations? Am J Hum Biol. 2012;24(5):710–2.
dc.sourceMenezes TM, Motta ME. Celiac disease prevalence in children and adolescents with myocarditis and dilated cardiomiopathy. J Pediatr (Rio J). 2012/10/25 ed. 2012;88(5):439–42.
dc.sourceAlmeida LM, Castro LC, Uenishi RH, de Almeida FC, Fritsch PM, Gandolfi L, et al. Decreased prevalence of celiac disease among Brazilian elderly. World J Gastroenterol. 2013;19(12):1930–5.
dc.sourceSkare T, Nisihara RM, Utiyama SRR. Is it worth investigating coeliac disease in patients with rheumatic disorders? Rheumatology (Oxford). 2013 Jan;52(1):217–8.
dc.sourceAraya M, Mondragón a, Pérez-Bravo F, Roessler JL, Alarcón T, Rios G, et al. Celiac disease in a Chilean population carrying Amerindian traits. J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):381–6.
dc.sourceCalderon HP, Valdes AP, Zemelman D V, Poniachik TJ, Hurtado HC, Garmendia MM, et al. [Frequency of celiac disease among patients with psoriasis]. Rev Med Chil. 2007;135(10):1296–303.
dc.sourceMadrid SA, Diaz SM, Hurtado HC, Aguilera OL, Mena UB. [Silent celiac disease among 21 patients with cryptogenic epilepsy]. Rev Med Chil. 2011;139(5):587–91.
dc.sourceSorell L, Garrote JA, Galvan JA, Velazco C, Edrosa CR, Arranz E. Celiac disease diagnosis in patients with giardiasis: high value of antitransglutaminase antibodies. Am J Gastroenterol. 2004;99(7):1330–2.
dc.sourceCastañeda C, Alvarez Fumero R, Sorell L, Galván JA CF. Screening for celiac disease in risk groups in Cuba. J Pediatr Gastroenterol Nutr. 2004;39:S211–2.
dc.sourceSorell L, Galván JA AB. Screening of celiac disease in Cuba. The Global Village of Coeliac Disease Perspectives on Coeliac Disease. 2005. p. 131–5.
dc.sourceGalván JA, Castañeda C, Rodríguez EA, Alvarez R, Turcaz N, Novoa LI, et al. Screening for celiac disease in a healthy Cubans children cohort from Pinar del Río province. 2005;II:5–7.
dc.sourceSanchez JC, Cabrera-Rode E, Sorell L, Galvan JA, Hernandez A, Molina G, et al. Celiac disease associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes. Autoimmunity. 2007;40(2):103–7.
dc.sourceGalván JA, Cabrera-Rode E, Molina G, Díaz-Horta O, Palenzuela DO, Novoa LI, et al. Celiac disease-associated antibodies in type 1 diabetes patients in Cuba. Biotecnol Apl. 2008;25(1):47–50.
dc.sourceSantana-Porbén S, Castellanos-Fernández M (2009) Malnutrition in adults with gastrointestinal disorders: A new reservoir of celiac disease? Rev Gastroenterol Mex. 74: 202–211.
dc.sourceGalvan JA, Lemos G, Fernandez de Cossio ME, Ruenes C, Martinez Y, Tejeda Y, et al. Silent celiac disease in a cohort of healthy adults. Autoimmunity. 2009;42(8):705–8.
dc.sourceGuerreiro Hernández AM, Villaescusa Blanco R, Morera Barrios LM, Alonso Valle M, Martínez Cardet L, Junco González Y. Detección de anticuerpos antigliadina y antitransglutaminasa en pacientes con clínica sugestiva de enfermedad celíaca. Rev Cubana Hematol Inmunol Hemoter 2010;28–32.
dc.sourceCintado A, Sorell L, Galván JA, Martínez L, Castañeda C, Fragoso T, et al. HLA DQA1*0501 and DQB1*02 in Cuban celiac patients. Hum Immunol. 2006;67(8):639–42.
dc.sourceSarmiento L, Galvan JA, Cabrera-Rode E, Aira L, Correa C, Sariego S, et al. Type 1 diabetes associated and tissue transglutaminase autoantibodies in patients without type 1 diabetes and coeliac disease with confirmed viral infections. J Med Virol. 2012 Jul;84(7):1049–53.
dc.sourceMadrazo de la Garza JA, Santiago -Lomelí M M-AJ et al. Prevalence of serum IgA anti-transglutaminase antibodies(anti-tTG) in an open population in Mexico. Rev Gastroenterol Mex. 2006;71 (suppl 118–9).
dc.sourceRemes-Troche JM, Ramírez-Iglesias MT, Rubio-Tapia A, Alonso-Ramos A, Velazquez A, Uscanga LF. Celiac disease could be a frequent disease in Mexico: prevalence of tissue transglutaminase antibody in healthy blood donors. J Clin Gastroenterol. 2006 Sep;40(8):697–700.
dc.sourceRemes-Troche JM, Rios-Vaca A, Ramírez-Iglesias MT, Rubio-Tapia A, Andrade-Zarate V, Rodríguez-Vallejo F, et al. High prevalence of celiac disease in Mexican Mestizo adults with type 1 diabetes mellitus. J Clin Gastroenterol. 2008;42(5):460–5.
dc.sourceWorona L, Coyote N VP. Prevalencia de la enfermedad celiaca en un grupo de pacientes con diabetes mellitus tipo I del Hospital Infantil de México. Rev Mex Gastroenterol. 2009;74:67.
dc.sourceRemes-Troche JM, Nuñez-Alvares C, Uscanga-Dominguez LF. Celiac disease in Mexican population: An update. Am J Gastroenterol. 2013;108(2):283–4.
dc.sourceArevalo F, Roe E, Arias-Stella-Castillo J, Cardenas J, Montes P, Monge E. Low serological positivity in patients with histology compatible with celiac disease in Peru. Rev Esp Enferm Dig. 2010;102(6):372–5.
dc.sourceLlanos O, Matzumura M, Tagle M, Huerta-Mercado J, Cedron H, Scavino J, et al. [Celiac disease: descriptive study at the Anglo American clinic]. Rev Gastroenterol Peru. 2012/10/02 ed. 2012;32(2):134–40.
dc.sourceLandaeta, N Fernandez L. Enfermedad Celiaca en pacientes pediátricos con Diábetes Mellitus Tipo 1. Gen. 2008;62(2):96–9.
dc.sourceLandaeta N, Rodríguez M, Fernandez A, Padrón D, Arredondo C. Screening para enfermedad celiaca en familiares de primer grado de niños celiacos. 2009;108–10.
dc.sourceRubio-Tapia C A, Ludvigsson JF, Brantner TL, Murray J a, Everhart JE. The Prevalence of Celiac Disease in the United States. Am J Gastroenterol.; 2012 Jul 31;(February):1–7.
dc.sourceKang JY, Kang AHY, Green A, Gwee KA, Ho KY. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013 Aug;38(3):226–45.
dc.sourceSans M. Admixture studies in Latin America: from the 20th to the 21st century. Hum Biol. 2000 Feb;72(1):155–77.
dc.sourcePena SDJ, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy F de SG, et al. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One. 2011 Jan;6(2):e17063.
dc.sourceAnaya J-M, Rojas-Villarraga A, García-Carrasco M. The autoimmune tautology: from polyautoimmunity and familial autoimmunity to the autoimmune genes. Autoimmune Dis. 2012 Jan;2012:297193.
dc.sourceBybrant MC, Örtqvist E, Lantz S, Grahnquist L. High prevalence of celiac disease in Swedish children and adolescents with type 1 diabetes and the relation to the Swedish epidemic of celiac disease: a cohort study. Scand J Gastroenterol. 2014 Jan;49(1):52–8.
dc.sourceConcannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med. 2009 Apr 16;360(16):1646–54.
dc.sourceGreco L, Romino R, Coto I, Di Cosmo N, Percopo S, Maglio M, et al. The first large population based twin study of coeliac disease. Gut. 2002 May;50(5):624–8.
dc.sourceCárdenas-Roldán J, Rojas-Villarraga A, Anaya J-M. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med. 2013 Jan;11:73.
dc.sourceNeuhausen SL, Steele L, Ryan S, Mousavi M, Pinto M, Osann KE, et al. Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. J Autoimmun. 2008 Sep;31(2):160–5.
dc.sourceWang S, Ray N, Rojas W, Parra M V, Bedoya G, Gallo C, et al. Geographic patterns of genome admixture in Latin American Mestizos. PLoS Genet. 2008 Mar;4(3):e1000037.
dc.sourceBourges H, Bengoa J, O´Donnell A. Historias de la Nutrición en América Latina. Soc Latinoam Nutr. 2009;
dc.sourcePalavecino EA, Mota AH, Awad J, Derosa S, Herrera M, Chertkoff L, et al. HLA and celiac disease in Argentina: involvement of the DQ subregion. Dis Markers. 1990;8(1):5–10.
dc.sourceHerrera M, Theiler G, Augustovski F, Chertkoff L, Fainboim L, DeRosa S, et al. Molecular characterization of HLA class II genes in celiac disease patients of Latin American Caucasian origin. Tissue Antigens. 1994;43(2):83–7.
dc.sourceSilva EM, Fernandes MI, Galvao LC, Sawamura R, Donadi EA. Human leukocyte antigen class II alleles in white Brazilian patients with celiac disease. J Pediatr Gastroenterol Nutr. 2000;31(4):391–4.
dc.sourcePérez-Bravo F, Araya M, Mondragón a, Ríos G, Alarcón T, Roessler JL, et al. Genetic differences in HLA-DQA1* and DQB1* allelic distributions between celiac and control children in Santiago, Chile. Hum Immunol. 1999 Mar;60(3):262–7.
dc.sourcePoggio Favotto RC, Mimbacas AB, Crispino B, Jasinski C, Cardoso H. Alelos HLA-DQB1 y DRB1 asociados con la enfermedad celíaca en pacientes hospitalarios Association between. Rev med Urug. 2001;17(2):107–13.
dc.sourceLandaeta N, Fernández-Mestre M, Rodríguez M, Padrón D, Medina M, Layrisse Z. Polimorfismo HLA-DQ en pacientes pediátricos con enfermedad Celíaca. Gen. 2008;62(2):92–5.
dc.sourceLayrisse Z, Guedez Y, Domínguez E, Paz N, Montagnani S, Matos M, et al. Extended HLA haplotypes in a Carib Amerindian population: the Yucpa of the Perija Range. Hum Immunol. 2001 Sep;62(9):992–1000.
dc.sourceGonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011 Jan;39(Database issue):D913–9.
dc.sourceKondrashova A, Mustalahti K, Kaukinen K, Viskari H, Volodicheva V, Haapala A-M, et al. Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med. 2008 Jan;40(3):223–31.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectEnfermedad celiaca
dc.subjectLatinoamérica
dc.subjectMeta-análisis
dc.subjectMeta-regresión
dc.titlePrevalencia de enfermedad celiaca en Latinoamérica: revisión sistemática de la literatura y meta-análisis
dc.typebachelorThesis


Este ítem pertenece a la siguiente institución